Annual EPS
-$26.28
-$7.20-37.74%
December 31, 2023
Summary
- As of March 2, 2025, CARA annual earnings per share is -$26.28, with the most recent change of -$7.20 (-37.74%) on December 31, 2023.
- During the last 3 years, CARA annual EPS has fallen by -$28.44 (-1316.67%).
- CARA annual EPS is now -1316.67% below its all-time high of $2.16, reached on December 31, 2020.
Performance
CARA EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EPS
-$2.76
+$1.68+37.84%
September 30, 2024
Summary
- As of March 2, 2025, CARA quarterly earnings per share is -$2.76, with the most recent change of +$1.68 (+37.84%) on September 30, 2024.
- Over the past year, CARA quarterly EPS has increased by +$1.68 (+37.84%).
- CARA quarterly EPS is now -113.61% below its all-time high of $20.28, reached on December 31, 2020.
Performance
CARA Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EPS
-$21.00
+$3.48+14.22%
September 30, 2024
Summary
- As of March 2, 2025, CARA TTM earnings per share is -$21.00, with the most recent change of +$3.48 (+14.22%) on September 30, 2024.
- Over the past year, CARA TTM EPS has increased by +$3.48 (+14.22%).
- CARA TTM EPS is now -396.61% below its all-time high of $7.08, reached on September 30, 2021.
Performance
CARA TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EPS Formula
EPS = Net Income - Preferred Dividends
Shares Outstanding
Net Income - Preferred Dividends
Shares Outstanding
Shares Outstanding
CARA EPS Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -37.7% | +37.8% | +14.2% |
| 3 y3 years | -1316.7% | +37.8% | +14.2% |
| 5 y5 years | -6.3% | +37.8% | +14.2% |
CARA EPS Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -37.7% | at low | -187.5% | +63.5% | -40.0% | +22.2% |
| 5 y | 5-year | -1316.7% | +12.1% | -113.6% | +63.5% | -396.6% | +31.4% |
| alltime | all time | -1316.7% | +12.1% | -113.6% | +71.6% | -396.6% | +31.4% |
Cara Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.76(-37.8%) | -$21.00(-14.2%) |
| Jun 2024 | - | -$4.44(-33.9%) | -$24.48(-9.3%) |
| Mar 2024 | - | -$6.72(-5.1%) | -$27.00(+3.2%) |
| Dec 2023 | -$26.28(+37.7%) | -$7.08(+13.5%) | -$26.16(+1.4%) |
| Sep 2023 | - | -$6.24(-10.3%) | -$25.80(+4.4%) |
| Jun 2023 | - | -$6.96(+18.4%) | -$24.72(+32.1%) |
| Mar 2023 | - | -$5.88(-12.5%) | -$18.72(-1.9%) |
| Dec 2022 | -$19.08(-8.6%) | -$6.72(+30.2%) | -$19.08(-4.2%) |
| Sep 2022 | - | -$5.16(+437.5%) | -$19.92(+32.8%) |
| Jun 2022 | - | -$0.96(-84.6%) | -$15.00(-29.8%) |
| Mar 2022 | - | -$6.24(-17.5%) | -$21.36(+2.9%) |
| Dec 2021 | -$20.88(-1066.7%) | -$7.56(+3050.0%) | -$20.76(-393.2%) |
| Sep 2021 | - | -$0.24(-96.7%) | $7.08(+126.9%) |
| Jun 2021 | - | -$7.32(+29.8%) | $3.12(-21.2%) |
| Mar 2021 | - | -$5.64(-127.8%) | $3.96(+83.3%) |
| Dec 2020 | $2.16(-107.2%) | $20.28(-582.9%) | $2.16(-108.5%) |
| Sep 2020 | - | -$4.20(-35.2%) | -$25.44(-15.5%) |
| Jun 2020 | - | -$6.48(-12.9%) | -$30.12(-1.6%) |
| Mar 2020 | - | -$7.44(+1.6%) | -$30.60(+2.4%) |
| Dec 2019 | -$29.88(+20.9%) | -$7.32(-17.6%) | -$29.88(+3.8%) |
| Sep 2019 | - | -$8.88(+27.6%) | -$28.80(+10.6%) |
| Jun 2019 | - | -$6.96(+3.6%) | -$26.04(+2.8%) |
| Mar 2019 | - | -$6.72(+7.7%) | -$25.32(+2.4%) |
| Dec 2018 | -$24.72 | -$6.24(+2.0%) | -$24.72(+4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$6.12(-1.9%) | -$23.64(+7.1%) |
| Jun 2018 | - | -$6.24(+2.0%) | -$22.08(+14.3%) |
| Mar 2018 | - | -$6.12(+18.6%) | -$19.32(-15.7%) |
| Dec 2017 | -$22.32(-11.4%) | -$5.16(+13.2%) | -$22.92(-16.6%) |
| Sep 2017 | - | -$4.56(+31.0%) | -$27.48(-1.7%) |
| Jun 2017 | - | -$3.48(-64.2%) | -$27.96(-7.5%) |
| Mar 2017 | - | -$9.72(0.0%) | -$30.24(+20.0%) |
| Dec 2016 | -$25.20(+110.0%) | -$9.72(+92.9%) | -$25.20(+28.0%) |
| Sep 2016 | - | -$5.04(-12.5%) | -$19.68(+16.3%) |
| Jun 2016 | - | -$5.76(+23.1%) | -$16.92(+19.5%) |
| Mar 2016 | - | -$4.68(+11.4%) | -$14.16(+18.0%) |
| Dec 2015 | -$12.00(+17.6%) | -$4.20(+84.2%) | -$12.00(+20.5%) |
| Sep 2015 | - | -$2.28(-24.0%) | -$9.96(-10.8%) |
| Jun 2015 | - | -$3.00(+19.0%) | -$11.16(+10.7%) |
| Mar 2015 | - | -$2.52(+16.7%) | -$10.08(-1.2%) |
| Dec 2014 | -$10.20(+504.4%) | -$2.16(-37.9%) | -$10.20(+11.0%) |
| Sep 2014 | - | -$3.48(+81.3%) | -$9.19(-37.0%) |
| Jun 2014 | - | -$1.92(-27.3%) | -$14.59(+48.6%) |
| Mar 2014 | - | -$2.64(+129.6%) | -$9.82(-7.0%) |
| Dec 2013 | -$1.69(-86.1%) | -$1.15(-87.1%) | -$10.56(-18.1%) |
| Sep 2013 | - | -$8.88(-411.7%) | -$12.90(+221.0%) |
| Jun 2013 | - | $2.85(-184.3%) | -$4.02(-41.5%) |
| Mar 2013 | - | -$3.38(-3.1%) | -$6.87(+96.9%) |
| Dec 2012 | -$12.17(-36.0%) | -$3.49 | -$3.49 |
| Dec 2011 | -$19.04 | - | - |
FAQ
- What is Cara Therapeutics annual earnings per share?
- What is the all time high annual EPS for Cara Therapeutics?
- What is Cara Therapeutics annual EPS year-on-year change?
- What is Cara Therapeutics quarterly earnings per share?
- What is the all time high quarterly EPS for Cara Therapeutics?
- What is Cara Therapeutics quarterly EPS year-on-year change?
- What is Cara Therapeutics TTM earnings per share?
- What is the all time high TTM EPS for Cara Therapeutics?
- What is Cara Therapeutics TTM EPS year-on-year change?
What is Cara Therapeutics annual earnings per share?
The current annual EPS of CARA is -$26.28
What is the all time high annual EPS for Cara Therapeutics?
Cara Therapeutics all-time high annual earnings per share is $2.16
What is Cara Therapeutics annual EPS year-on-year change?
Over the past year, CARA annual earnings per share has changed by -$7.20 (-37.74%)
What is Cara Therapeutics quarterly earnings per share?
The current quarterly EPS of CARA is -$2.76
What is the all time high quarterly EPS for Cara Therapeutics?
Cara Therapeutics all-time high quarterly earnings per share is $20.28
What is Cara Therapeutics quarterly EPS year-on-year change?
Over the past year, CARA quarterly earnings per share has changed by +$1.68 (+37.84%)
What is Cara Therapeutics TTM earnings per share?
The current TTM EPS of CARA is -$21.00
What is the all time high TTM EPS for Cara Therapeutics?
Cara Therapeutics all-time high TTM earnings per share is $7.08
What is Cara Therapeutics TTM EPS year-on-year change?
Over the past year, CARA TTM earnings per share has changed by +$3.48 (+14.22%)